Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Deyan Davidov
The Hemoglobin Level as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Cis-Platinum
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Related publications
Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer
Journal of Clinical & Cellular Immunology
Pre‑treatment Hemoglobin Levels Are an Independent Prognostic Factor in Patients With Non‑small Cell Lung Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
RRM1 Expression and the Clinicopathological Characteristics of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine
OncoTargets and Therapy
Oncology
Pharmacology
P3.01-10 Dyspnea as a Prognostic Factor in Hispanic Patients With Non-Small Cell Lung Cancer Cohort
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Human Immunodeficiency Virus Infection as a Prognostic Factor in Surgical Patients With Non-Small Cell Lung Cancer
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
A Multi-Center, Phase II Trial of Nab-Paclitaxel and Gemcitabine in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Cancer Management and Research
Oncology
Cytidine Deaminase Enzymatic Activity Is a Prognostic Biomarker in Gemcitabine/Platinum-Treated Advanced Non-Small-Cell Lung Cancer: A Prospective Validation Study
British Journal of Cancer
Cancer Research
Oncology
Serum Neuron Specific Enolase (NSE) Level in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy: A Possible Prognostic Indicator
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
